anti-CD19 human antibodies (Genmab)

N/A

Report date: 2025/03/14 16:24:56

Base Information

Drug Nameanti-CD19 human antibodies (Genmab)
Drug Alias Nameanti-CD19 human antibodies (Bristol-Myers Squibb)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionB-lymphocyte antigen CD19 inhibitors
TargetsB-lymphocyte antigen CD19
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesGenmab A/S
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A